ANKS4B
gene geneOn this page
Also known as FLJ38819HARP
Summary
ANKS4B (ankyrin repeat and sterile alpha motif domain containing 4B, HGNC:26795) is a protein-coding gene on chromosome 16p12.2, encoding Ankyrin repeat and SAM domain-containing protein 4B (Q8N8V4). As part of the intermicrovillar adhesion complex/IMAC plays a role in epithelial brush border differentiation, controlling microvilli organization and length.
Involved in brush border assembly; protein localization to microvillus; and protein-containing complex assembly. Located in brush border and microvillus.
Source: NCBI Gene 257629 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 50 total
- MANE Select transcript:
NM_145865
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26795 |
| Approved symbol | ANKS4B |
| Name | ankyrin repeat and sterile alpha motif domain containing 4B |
| Location | 16p12.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ38819, HARP |
| Ensembl gene | ENSG00000175311 |
| Ensembl biotype | protein_coding |
| OMIM | 609901 |
| Entrez | 257629 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000311620
RefSeq mRNA: 1 — MANE Select: NM_145865
NM_145865
CCDS: CCDS42130
Canonical transcript exons
ENST00000311620 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001189612 | 21233699 | 21233901 |
| ENSE00001234462 | 21249731 | 21253850 |
Expression profiles
Bgee: expression breadth broad, 44 present calls, max score 87.80.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.6728 / max 140.5843, expressed in 80 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 153100 | 0.6728 | 80 |
Top tissues by expression
125 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 87.80 | gold quality |
| duodenum | UBERON:0002114 | 86.54 | gold quality |
| rectum | UBERON:0001052 | 84.09 | gold quality |
| liver | UBERON:0002107 | 82.71 | gold quality |
| right lobe of liver | UBERON:0001114 | 80.01 | gold quality |
| small intestine | UBERON:0002108 | 75.61 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 74.90 | gold quality |
| transverse colon | UBERON:0001157 | 73.81 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 73.79 | silver quality |
| adult mammalian kidney | UBERON:0000082 | 73.74 | gold quality |
| gall bladder | UBERON:0002110 | 70.11 | gold quality |
| colonic epithelium | UBERON:0000397 | 69.91 | gold quality |
| kidney | UBERON:0002113 | 69.00 | gold quality |
| intestine | UBERON:0000160 | 65.20 | gold quality |
| islet of Langerhans | UBERON:0000006 | 63.66 | gold quality |
| vermiform appendix | UBERON:0001154 | 61.57 | gold quality |
| colon | UBERON:0001155 | 60.64 | gold quality |
| cortex of kidney | UBERON:0001225 | 56.28 | gold quality |
| sural nerve | UBERON:0015488 | 55.45 | gold quality |
| cerebellum | UBERON:0002037 | 53.26 | gold quality |
| cerebellar cortex | UBERON:0002129 | 53.24 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 53.08 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 52.40 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 51.66 | gold quality |
| pancreas | UBERON:0001264 | 49.39 | gold quality |
| metanephros cortex | UBERON:0010533 | 48.17 | gold quality |
| stomach | UBERON:0000945 | 44.66 | gold quality |
| muscle tissue | UBERON:0002385 | 43.62 | gold quality |
| body of stomach | UBERON:0001161 | 43.50 | gold quality |
| mucosa of stomach | UBERON:0001199 | 42.76 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.75 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): ESR1, HNF4A
miRNA regulators (miRDB)
68 targeting ANKS4B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-6817-3P | 99.79 | 68.35 | 2126 |
| HSA-MIR-4668-5P | 99.79 | 70.58 | 3782 |
| HSA-MIR-1273H-5P | 99.77 | 66.32 | 2471 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-6779-5P | 99.70 | 65.76 | 2363 |
| HSA-MIR-30B-3P | 99.70 | 65.76 | 2325 |
| HSA-MIR-3689A-3P | 99.70 | 65.73 | 2306 |
| HSA-MIR-3689B-3P | 99.70 | 65.71 | 2311 |
| HSA-MIR-3689C | 99.70 | 65.71 | 2311 |
| HSA-MIR-5580-3P | 99.70 | 69.41 | 2052 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-580-3P | 99.67 | 69.23 | 1841 |
| HSA-MIR-466 | 99.67 | 70.85 | 2863 |
| HSA-MIR-6134 | 99.63 | 65.68 | 1537 |
| HSA-MIR-7152-5P | 99.60 | 69.33 | 2094 |
| HSA-MIR-885-5P | 99.59 | 68.59 | 879 |
| HSA-MIR-4649-3P | 99.56 | 66.90 | 1783 |
Literature-anchored findings (GeneRIF, showing 3)
- ankyrin repeat and sterile alpha motif domain containing 4B (ANKS4B) localizes to the tips of adherent brush border microvilli and is essential for intermicrovillar adhesion (PMID:26812018)
- Myosin VII, USH1C, and ANKS4B or USH1G Together Form Condensed Molecular Assembly via Liquid-Liquid Phase Separation. (PMID:31644917)
- A cryptic sequence targets the adhesion complex scaffold ANKS4B to apical microvilli to promote enterocyte brush border assembly. (PMID:32636301)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | anks4b | ENSDARG00000036846 |
| mus_musculus | Anks4b | ENSMUSG00000030909 |
| rattus_norvegicus | Anks4b | ENSRNOG00000046181 |
| drosophila_melanogaster | Sans | FBGN0033785 |
Paralogs (1): USH1G (ENSG00000182040)
Protein
Protein identifiers
Ankyrin repeat and SAM domain-containing protein 4B — Q8N8V4 (reviewed: Q8N8V4)
Alternative names: Harmonin-interacting ankyrin repeat-containing protein
All UniProt accessions (1): Q8N8V4
UniProt curated annotations — full annotation on UniProt →
Function. As part of the intermicrovillar adhesion complex/IMAC plays a role in epithelial brush border differentiation, controlling microvilli organization and length. Plays a role in assembly of the complex. May play a role in cellular response to endoplasmic reticulum stress.
Subunit / interactions. Part of the IMAC/intermicrovillar adhesion complex/intermicrovillar tip-link complex composed of ANKS4B, MYO7B, USH1C, CDHR2 and CDHR5. Interacts with USH1C; the interaction is direct and is required for ANKS4B localization to the tip of microvilli. Interacts with MYO7B; the interaction is direct. May interact with HSPA5.
Subcellular location. Cell projection. Microvillus.
Tissue specificity. Expressed in kidney and small intestine.
RefSeq proteins (1): NP_665872* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001660 | SAM | Domain |
| IPR002110 | Ankyrin_rpt | Repeat |
| IPR013761 | SAM/pointed_sf | Homologous_superfamily |
| IPR036770 | Ankyrin_rpt-contain_sf | Homologous_superfamily |
| IPR037601 | ANKS4B_SAM | Domain |
Pfam: PF00536, PF12796
UniProt features (16 total): region of interest 4, repeat 3, compositionally biased region 2, mutagenesis site 2, chain 1, short sequence motif 1, modified residue 1, domain 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N8V4-F1 | 70.57 | 0.42 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 283
Mutagenesis-validated functional residues (2):
| Position | Phenotype |
|---|---|
| 48 | decreased localization to microvilli. |
| 417 | decreased interaction with ush1c. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 64 (showing top):
GSE45365_NK_CELL_VS_CD8_TCELL_DN, GOBP_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS, GOCC_APICAL_PART_OF_CELL, chr16p12, GOCC_MICROVILLUS, GOCC_CLUSTER_OF_ACTIN_BASED_CELL_PROJECTIONS, GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK, GOCC_ACTIN_BASED_CELL_PROJECTION, GOCC_ORGANELLE_SUBCOMPARTMENT, GOCC_BRUSH_BORDER, BAKKER_FOXO3_TARGETS_DN, SERVITJA_ISLET_HNF1A_TARGETS_DN, GOBP_BRUSH_BORDER_ASSEMBLY, GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_UP, HHEX_TARGET_GENES
GO Biological Process (5): cell differentiation (GO:0030154), response to endoplasmic reticulum stress (GO:0034976), protein-containing complex assembly (GO:0065003), protein localization to microvillus (GO:1904106), brush border assembly (GO:1904970)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (6): endoplasmic reticulum membrane (GO:0005789), plasma membrane (GO:0005886), microvillus (GO:0005902), brush border (GO:0005903), cell projection (GO:0042995), plasma membrane bounded cell projection (GO:0120025)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular component assembly | 2 |
| cellular developmental process | 1 |
| cellular response to stress | 1 |
| protein-containing complex organization | 1 |
| protein localization to actin cytoskeleton | 1 |
| binding | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| membrane | 1 |
| cell periphery | 1 |
| actin filament bundle | 1 |
| actin-based cell projection | 1 |
| microvillus | 1 |
| apical part of cell | 1 |
| cluster of actin-based cell projections | 1 |
| cellular anatomical structure | 1 |
| cell projection | 1 |
| plasma membrane region | 1 |
Protein interactions and networks
STRING
996 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ANKS4B | MYO7B | Q6PIF6 | 899 |
| ANKS4B | E9PNW1 | E9PNW1 | 887 |
| ANKS4B | CDHR5 | Q9HBB8 | 802 |
| ANKS4B | CDHR2 | Q9BYE9 | 790 |
| ANKS4B | PLA2G12B | Q9BX93 | 539 |
| ANKS4B | ABHD15 | Q6UXT9 | 526 |
| ANKS4B | N4BP2L1 | Q5TBK1 | 507 |
| ANKS4B | ZNF732 | B4DXR9 | 505 |
| ANKS4B | ZSWIM3 | Q96MP5 | 484 |
| ANKS4B | SLC35D1 | Q9NTN3 | 434 |
| ANKS4B | CDH23 | Q9H251 | 430 |
| ANKS4B | LDLRAD1 | Q5T700 | 426 |
| ANKS4B | SLC7A14 | Q8TBB6 | 406 |
| ANKS4B | TM4SF4 | P48230 | 387 |
| ANKS4B | MYO7A | P78427 | 383 |
IntAct
12 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ANKS4B | LRRK2 | psi-mi:“MI:0407”(direct interaction) | 0.620 |
| LRRK2 | ANKS4B | psi-mi:“MI:0407”(direct interaction) | 0.620 |
| ANKS4B | USH1C | psi-mi:“MI:0915”(physical association) | 0.560 |
| ANKS4B | MFHAS1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ANKS4B | psi-mi:“MI:0407”(direct interaction) | 0.440 | |
| ANKS4B | PLEC | psi-mi:“MI:0915”(physical association) | 0.400 |
| ANKS4B | MPP7 | psi-mi:“MI:0914”(association) | 0.350 |
| ANKS4B | USH1C | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (11): ANKS4B (Biochemical Activity), ANKS4B (Reconstituted Complex), ANKS4B (Reconstituted Complex), ANKS4B (Two-hybrid), ANKS4B (Proximity Label-MS), BANP (Affinity Capture-MS), USH1C (Affinity Capture-MS), MPP7 (Affinity Capture-MS), ANKS4B (Cross-Linking-MS (XL-MS)), ATP6V1E1 (Cross-Linking-MS (XL-MS)), APP (Reconstituted Complex)
ESM2 similar proteins: A0JPH7, A1A5Q0, B0R034, E1BTG2, E1C065, E1C760, F1MUG2, F7AEX0, G3XA57, O60308, P30306, P48966, Q02225, Q0IID7, Q0VBD2, Q14B46, Q28E45, Q28FA8, Q3UHZ5, Q4KM37, Q5EAW4, Q5FWH3, Q5JTW2, Q5RHY1, Q5XGX5, Q60949, Q6GQN0, Q6INA9, Q6NTY8, Q6NU40, Q6P5Q4, Q7L590, Q80U87, Q8BN58, Q8BXR9, Q8BZN6, Q8C5W4, Q8GT06, Q8K3X6, Q8N8V4
Diamond homologs: O94830, Q495M9, Q6NZC7, Q80T11, Q80Y98, Q80YA3, Q8K3X6, Q8N8V4, Q9Y6Y8, O14593, Q3KP44, Q8BLD6, Q9Z205, P0C0T2, Q24009, Q5M9H0, Q5U4T7, Q5XJ13, Q68DC2, Q6GQX6, Q6ZW76, Q99MQ1, Q9CZK6, Q9H694, Q9IA00, O00562, O35954, P43125, Q12204, Q3UHE1, Q5U2N3, Q6ZPQ6, Q9BZ71, Q9BZ72
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| SMURF1 | unknown | ANKS4B | ubiquitination |
Disease & clinical
Clinical variants and AI predictions
ClinVar
50 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 42 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
197 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:21233898:GAGG:G | donor_gain | 1.0000 |
| 16:21233900:GG:G | donor_gain | 1.0000 |
| 16:21233901:GG:G | donor_gain | 1.0000 |
| 16:21233902:G:GA | donor_loss | 1.0000 |
| 16:21233902:G:GG | donor_gain | 1.0000 |
| 16:21233903:T:TC | donor_loss | 1.0000 |
| 16:21249727:CTA:C | acceptor_loss | 1.0000 |
| 16:21249728:TA:T | acceptor_loss | 1.0000 |
| 16:21249729:A:AG | acceptor_gain | 1.0000 |
| 16:21249729:AGAG:A | acceptor_gain | 1.0000 |
| 16:21249729:AGAGG:A | acceptor_gain | 1.0000 |
| 16:21249730:G:GG | acceptor_gain | 1.0000 |
| 16:21249730:GA:G | acceptor_gain | 1.0000 |
| 16:21249730:GAGG:G | acceptor_gain | 1.0000 |
| 16:21249730:GAGGG:G | acceptor_gain | 1.0000 |
| 16:21233899:AGG:A | donor_gain | 0.9900 |
| 16:21233900:GGG:G | donor_gain | 0.9900 |
| 16:21237577:G:GT | donor_gain | 0.9900 |
| 16:21237582:G:T | donor_gain | 0.9900 |
| 16:21249728:TAGAG:T | acceptor_gain | 0.9900 |
| 16:21249727:CTAGA:C | acceptor_gain | 0.9800 |
| 16:21233899:AGGGT:A | donor_gain | 0.9700 |
| 16:21233900:GGGT:G | donor_gain | 0.9700 |
| 16:21233901:GGT:G | donor_gain | 0.9700 |
| 16:21233902:GT:G | donor_gain | 0.9700 |
| 16:21234166:G:T | donor_gain | 0.9700 |
| 16:21237586:G:GT | donor_gain | 0.9700 |
| 16:21249726:TCTAG:T | acceptor_gain | 0.9700 |
| 16:21249727:CTAG:C | acceptor_gain | 0.9700 |
| 16:21249728:TAG:T | acceptor_gain | 0.9700 |
AlphaMissense
2773 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:21233841:C:A | P35H | 0.996 |
| 16:21233763:C:A | A9D | 0.995 |
| 16:21250711:T:C | L382P | 0.993 |
| 16:21233841:C:G | P35R | 0.992 |
| 16:21233856:C:A | A40D | 0.992 |
| 16:21249784:C:A | A73D | 0.992 |
| 16:21249880:C:A | A105D | 0.992 |
| 16:21233880:T:C | L48P | 0.991 |
| 16:21249751:A:T | D62V | 0.991 |
| 16:21249781:C:A | A72E | 0.991 |
| 16:21249760:G:T | G65V | 0.989 |
| 16:21233787:T:C | L17P | 0.988 |
| 16:21233853:C:A | A39E | 0.988 |
| 16:21249783:G:C | A73P | 0.988 |
| 16:21249769:C:G | P68R | 0.987 |
| 16:21249808:T:A | V81D | 0.987 |
| 16:21249817:T:C | L84P | 0.987 |
| 16:21233795:G:C | A20P | 0.986 |
| 16:21233852:G:C | A39P | 0.986 |
| 16:21233855:G:C | A40P | 0.986 |
| 16:21233865:G:T | G43V | 0.986 |
| 16:21233796:C:A | A20D | 0.985 |
| 16:21233864:G:T | G43W | 0.985 |
| 16:21249916:T:C | L117P | 0.985 |
| 16:21249769:C:A | P68H | 0.984 |
| 16:21249772:T:C | L69P | 0.984 |
| 16:21249879:G:C | A105P | 0.983 |
| 16:21249751:A:C | D62A | 0.982 |
| 16:21249752:C:A | D62E | 0.982 |
| 16:21249752:C:G | D62E | 0.982 |
dbSNP variants (sampled 300 via entrez): RS1000115582 (16:21249582 G>A), RS1000584447 (16:21235720 C>G), RS1000873649 (16:21236966 T>C), RS1000928051 (16:21248286 G>A,C,T), RS1000928439 (16:21242355 T>C), RS1000959339 (16:21248622 C>T), RS1001519679 (16:21244199 T>C), RS1001550812 (16:21242859 A>C), RS1001671435 (16:21250690 T>C), RS1001707997 (16:21237082 G>A), RS1001997361 (16:21241760 T>C), RS1002065181 (16:21243236 A>C,G), RS1002141285 (16:21238494 TATAC>T), RS1002284303 (16:21241549 T>A), RS1002451483 (16:21247541 G>A)
Disease associations
OMIM: gene MIM:609901 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003226_4 | Pelvic organ prolapse | 4.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression, decreases expression | 2 |
| Acetaminophen | increases expression, decreases expression | 2 |
| Benzo(a)pyrene | affects methylation, decreases expression, increases methylation | 2 |
| Cyclosporine | decreases expression | 2 |
| Aflatoxin B1 | affects expression, decreases expression, decreases methylation | 2 |
| propionaldehyde | decreases expression | 1 |
| beta-lapachone | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| pentanal | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Air Pollutants | decreases expression | 1 |
| Aldehydes | decreases expression | 1 |
| Cisplatin | increases expression | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Quercetin | decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Silver | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): pelvic organ prolapse